Literature DB >> 21476117

Reliability and validity of the Taiwan (Mandarin Chinese) version of the chronic respiratory questionnaire.

Nai-Hsin Meng1, Fei-Na Chen, Sui-Foon Lo, Sui-Fon Lo, Wei-Erh Cheng.   

Abstract

PURPOSE: The chronic respiratory disease questionnaire (CRQ) has been validated and proved useful in assessing therapies for pulmonary diseases. We translated the CRQ into a Taiwan (Mandarin Chinese) version and surveyed its validity and reliability.
METHODS: The CRQ includes 20 items divided into four domains: dyspnea, fatigue, emotional function, and mastery. We followed a forward-back translation procedure to create the Taiwan version. A cross-sectional survey was conducted among outpatients with chronic obstructive pulmonary disease. Participants underwent tests including the CRQ, the medical outcomes study short form (SF-36), the St. George respiratory questionnaire (SGRQ), lung function tests (LFTs), and a graded exercise test (GET). We used Cronbach's alpha to evaluate the internal consistency of the CRQ, intraclass coefficient for test-retest reliability, and Spearman's correlation for validity.
RESULTS: Thirty-six men and 4 women (mean age 67.9 ± 9.9 years) were recruited. Evidence of good internal consistency, test-retest reliability, convergent, discriminant, concurrent, and construct validity of the CRQ was shown. Spearman's correlation showed moderate-to-strong correlation between the CRQ scores and scores of the SGRQ, subscales of the SF-36, and the results of LFTs and GET.
CONCLUSIONS: The Taiwan version of the CRQ shows good validity, internal consistency, and test-retest reliability.

Entities:  

Mesh:

Year:  2011        PMID: 21476117     DOI: 10.1007/s11136-011-9906-7

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  18 in total

1.  Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation.

Authors:  G H Guyatt; D R King; D H Feeny; D Stubbing; R S Goldstein
Journal:  J Clin Epidemiol       Date:  1999-03       Impact factor: 6.437

Review 2.  ATS/ACCP Statement on cardiopulmonary exercise testing.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2003-01-15       Impact factor: 21.405

3.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.

Authors:  P W Jones; F H Quirk; C M Baveystock; P Littlejohns
Journal:  Am Rev Respir Dis       Date:  1992-06

4.  Exercise rehabilitation and chronic obstructive pulmonary disease stage.

Authors:  M J Berry; W J Rejeski; N E Adair; D Zaccaro
Journal:  Am J Respir Crit Care Med       Date:  1999-10       Impact factor: 21.405

5.  A comparison of three disease-specific and two generic health-status measures to evaluate the outcome of pulmonary rehabilitation in COPD.

Authors:  S J Singh; S C Sodergren; M E Hyland; J Williams; M D Morgan
Journal:  Respir Med       Date:  2001-01       Impact factor: 3.415

6.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

7.  Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.

Authors:  T L Griffiths; M L Burr; I A Campbell; V Lewis-Jenkins; J Mullins; K Shiels; P J Turner-Lawlor; N Payne; R G Newcombe; A A Ionescu; J Thomas; J Tunbridge; A A Lonescu
Journal:  Lancet       Date:  2000-01-29       Impact factor: 79.321

8.  Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled study.

Authors:  M R Alexander; W L Dull; J E Kasik
Journal:  JAMA       Date:  1980-11-21       Impact factor: 56.272

9.  Reliability and validity of the chronic respiratory questionnaire (CRQ).

Authors:  P J Wijkstra; E M TenVergert; R Van Altena; V Otten; D S Postma; J Kraan; G H Koëter
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

10.  Effects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction.

Authors:  M L Eaton; F M MacDonald; T R Church; D E Niewoehner
Journal:  Chest       Date:  1982-11       Impact factor: 9.410

View more
  3 in total

1.  Validation of the chronic respiratory questionnaire in the Colombian population with chronic obstructive pulmonary disease.

Authors:  Jorge M Estrada Álvarez; Ximena Ossa García; Carmen I del Quijano del Gordo; Luis Bustos; Diana P Urina; Celso F Pérez; John E Ossa; Edwin Moreno Rojas
Journal:  Qual Life Res       Date:  2015-02-12       Impact factor: 4.147

2.  Translation and validation of the Malay version of Shiffman-Jarvik withdrawal scale and cessation self-efficacy questionnaire: a review of psychometric properties.

Authors:  Eng Wah Teo; Yuin Yi Lee; Selina Khoo; Tony Morris
Journal:  Health Qual Life Outcomes       Date:  2015-04-09       Impact factor: 3.186

Review 3.  Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement.

Authors:  Paul Jones; Marc Miravitlles; Thys van der Molen; Karoly Kulich
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-10-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.